DAVID ALLEN SACK
Pilots at Bellvale Rd, Fallston, MD
License number
Maryland A1651343
Issued Date
Oct 2015
Expiration Date
Oct 2017
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
2117 Bellvale Rd, Fallston, MD 21047
Professional information
Oral Rehydration Composition
US Patent:
2003019, Oct 16, 2003
Filed:
Apr 16, 2002
Appl. No.:
10/125367
Inventors:
Cheryl Mitchell - Stockton CA, US
David Sack - Fallston MD, US
David Sack - Fallston MD, US
International Classification:
A61K033/14, A61K035/78, A61K031/70
US Classification:
424/676000, 424/750000, 514/023000
Abstract:
A rehydration composition and oral delivery system is provided that allows for enhanced functional ingredient delivery when ingested orally as a water based solution. The rehydration composition comprises a low fiber colloidal hydrolyzed rice carbohydrate ingredient having, on a dry weight basis, less than 0.1% fiber and between 0.5% and 1.0% protein and between 0-0.5% and 1.0% fat, and having a dextrose equivalency (DE) value within the approximate range of 20-30 (commonly DE 25), and electrolytes such as sodium, potassium, citrate, and/or bicarbonate. The rehydration composition, which is concentrated or dried, becomes an oral rehydration solution (ORS) when mixed with water for oral consumption. The rehydration composition, when mixed with active ingredients such as vaccines, drugs, amino acids, mineral salts, vitamins, nutraceuticals, probiotics, prebiotics, flavors, or nutritive or non-nutritive sweeteners, is referred to as an oral delivery system. This oral delivery system may then be further diluted in a water base to produce an oral delivery solution that is suitable for oral ingestion by a user.
Non-Invasive Test For Gastric Acid
US Patent:
4548805, Oct 22, 1985
Filed:
Dec 27, 1983
Appl. No.:
6/566032
Inventors:
David A. Sack - Fallston MD
Charles B. Stephensen - Baltimore MD
Charles B. Stephensen - Baltimore MD
International Classification:
A61K 4900
US Classification:
424 9
Abstract:
A non-invasive method for determining gastric acidity in humans, using oral magnesium metal powder while measuring the hydrogen gas response in exhaled breath and belches. The magnesium reacts with hydrochloric acid in the stomach liberating hydrogen and the magnitude of the hydrogen released is correlated with the amount of gastric acid produced.
Buffer Composition Base And Method Of Formulation For Oral Vaccine Delivery
US Patent:
5741680, Apr 21, 1998
Filed:
Sep 3, 1996
Appl. No.:
8/706447
Inventors:
David A. Sack - Fallston MD
Assignee:
Cera Products, Inc. - Columbia MD
International Classification:
C12P 1414, A61K 39106, A01N 5900, C12N 706
US Classification:
435 99
Abstract:
This invention provides for a composition base and method of formulation to allow for oral vaccine delivery. The composition base is mixed with the oral vaccine and includes a carbohydrate composition having a dextrose equivalency value within the approximate range of 35-50. The buffer composition includes an electrolyte composition blended with the carbohydrate composition and the blended carbohydrate and electrolyte compositions are mixed each with respect to the other and then with the vaccine for oral ingestion by a user.